Skip to content
Screener

BioSig Technologies, Inc. STEX Q1 2026 Annual earnings

Reported May 18, 2026 · Before market open

EPS-$0.27Miss by $0.22
Revenue estimate$1.0M
EPS estimate-$0.05

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$300.0K
EPS estimate-$0.03

Financials

Q1 2026

Income statement

See full
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$38.9M+944%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$103.41M+623%

Returns & leverage

See full
Return on equity-627.1%—
Current ratio13.9×+11.5×

FAQ

When did BioSig Technologies, Inc. report Q1 2026 earnings?
BioSig Technologies, Inc. (STEX) reported Q1 2026 earnings on May 18, 2026 before market open.
What were BioSig Technologies, Inc.'s Q1 2026 revenue and EPS?
BioSig Technologies, Inc. reported eps of $-0.27 for Q1 2026.
Did BioSig Technologies, Inc. beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.05 by $0.22.
How did BioSig Technologies, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 99.6% from $-0.14.
Where can I find BioSig Technologies, Inc.'s Q1 2026 SEC filings?
You can read the 10-K periodic report (0001493152-26-014376) directly on SEC EDGAR. The filing index links above go to sec.gov.